EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children

Sabeen Abid Khan iD, Misbah Fakih iD, Nida Taufiq iD, Afaaf Ahmerin, Asfand Bangash, Munir Iqbal Malik

Clinical Medicine Insights: Pediatrics · 2024-01 · 18

DOI: 10.1177/11795565241236176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Insights: Pediatrics, online erschienen am 06.03.2024. Verfasst von Sabeen Abid Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shifa College of Medicine, Tameer-e-Millat University, Islamabad, Pakistan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary Tyrosinemia Type 1 (HT1), a rare autosomal recessive metabolic disorder, arises from fumarylacetoacetate (FAH) enzyme deficiency, resulting in toxic metabolite buildup. It manifests in acute, subacute, and chronic forms, with early diagnosis and Nitisinone treatment being vital.

Objectives

The study aims to highlight the different clinical presentations of Hereditary Tyrosinemia type 1 in a cohort of Pakistani children.

Design

Retrospective observational study. Methodology: All patients diagnosed with HT1 at Shifa International Hospital, Islamabad and Pak Emirates Military Hospital, Rawalpindi between 2010 and 2023 were included. Information was collected regarding age, gender, symptoms, physical signs, and laboratory results.

Results

The study identified 6 cases of HT1. The average age at presentation was 8 months, with a mean delay in diagnosis of 26.8 months. Males were 4 (66.7%) and 2 (33.3%) were females. All patients had underlying liver disease presenting as abdominal distension with hepatosplenomegaly and accompanying growth failure. Four cases presented with rickets, 2 of which had hypophosphatemic rickets. Urine for succinylacetone was raised in all patients. Alpha fetoprotein was raised but hepatocellular carcinoma was diagnosed in 1 patient only. Low protein diet, and vitamin supplements were used for management. Five of the 6 patients died within 2 years of diagnosis.

Conclusion

Delayed referrals and unavailability of Nitisinone are the major challenges in diagnosing and treating HT1 in Pakistan.

Schlagwörter

Stichwörter der Autor:innen

Hereditary tyrosinemia type 1Pakistanfumaryl acetoacetate hydrolasehepatosplenomegalyliver failurerickets

Autor:innen und Institutionen

  • Shifa College of Medicine, Tameer-e-Millat University, Islamabad, Pakistan.
  • Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan.

ORCID-Profile: Sabeen Abid Khan, Misbah Fakih, Nida Taufiq

Zitieren

APA

Khan, S. A., Fakih, M., Taufiq, N., Ahmerin, A., Bangash, A., & Iqbal Malik, M. (2024). Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children. Clinical Medicine Insights: Pediatrics, 18. https://doi.org/10.1177/11795565241236176

Vancouver

Khan SA, Fakih M, Taufiq N, Ahmerin A, Bangash A, Iqbal Malik M. Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children. Clinical Medicine Insights: Pediatrics. 2024;18. doi:10.1177/11795565241236176

BibTeX
@article{Khan2024,
  author = {Khan, Sabeen Abid and Fakih, Misbah and Taufiq, Nida and Ahmerin, Afaaf and Bangash, Asfand and Iqbal Malik, Munir},
  title = {Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children},
  journal = {Clinical Medicine Insights: Pediatrics},
  year = {2024},
  volume = {18},
  doi = {10.1177/11795565241236176}
}
Kostenlos starten →